Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Another Record-High Graduation Success Rate For UNC Student-Athletes
For the sixth consecutive year, UNC student-athletes established a record-high multi-year graduation rate as reported in the NCAA's annual Graduation Success Rates. The overall student-athlete...
Fri Nov 21, 2025

Carolina Insider Podcast: UNC Football hosts Duke, Basketball recap, Dan Shulman, Dr. Wesley Burks
Jones Angell and Adam Lucas preview UNC Football's matchup with Duke (7:04). Tar Heel Basketball took care of Navy and now heads to Florida for...
Fri Nov 21, 2025

Chansky’s Notebook: Sorry, We Miss You
Why do you think the Beat Duke Parade fizzled out? There may be a lot of reasons why college parades with whacky floats are things...
Wed Nov 19, 2025

Chapel Hill’s He’s Not Here Among The Athletic’s ‘Top 10 College Bars’ for 2025
A downtown Chapel Hill staple long known for its appeal to both UNC students, Tar Heel fans and visitors recently landed on a national list...
Wed Nov 19, 2025